Business Standard

Monday, December 23, 2024 | 11:16 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

AstraZeneca's Covid-19 vaccine's benefits outweigh risk, says EU regulator

Europe's Covid-19 toll surpassed the grim milestone of over 900,000 deaths.

AstraZeneca wasn't the obvious choice to partner up with Oxford when scientists there started developing a coronavirus shot. Photographer: Mikael Sjoberg/Bloomberg
Premium

A WHO committee of experts was reviewing the cases and was expected to issue a statement by the end of the day

Agencies
Europe’s medicines watchdog said on Tuesday the benefits of AstraZeneca's Covid-19 vaccine continue to outweigh the risks after several countries halted its use due to concerns about blood clots.
 
EMA Executive Director Emer Cooke said there was no indication that the blood clot incidents, which she called “very rare” had been caused by the vaccine, but that experts were assessing that possibility.
 
Meanwhile, according to news agency AFP’s tally, Europe’s Covid-19 toll surpassed the grim milestone of over 900,000 deaths.
 
Trust in the safety of the vaccines was paramount and the agency was carrying out a case-by-case

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in